Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN News Highlights

More »
Jan 16, 2007

Invitrogen Partners with Wave Biotech, LLC

  • Invitrogen and Wave Biotech  entered into a partnership to supply media-filled disposable bioreactors. Under the agreement, Invitrogen will offer its GIBCO® brand cell culture media products to Wave Bioreactor® users in filled Cellbag® brand disposable bioreactor bags.

    Invitrogen will offer both standard and custom media products in the standard O-series Cellbag format.

    “This partnership creates a tremendously convenient solution for bioreactor users and will substantially reduce customer prep time and the inherent contamination risks and raw materials tracking issues associated with self-filling of bioreactor vessels,” said Nicolas Barthelemy, senior vp of Invitrogen’s cell culture systems division.



Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »